Skip to main content
Article thumbnail
Location of Repository

High concentrations of morphine sensitize and activate mouse dorsal root ganglia via TRPV1 and TRPA1 receptors

By Alexander B Forster, Peter W Reeh, Karl Messlinger and Michael JM Fischer
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2000). Ahern GP: Induction of vanilloid receptor channel activity by protein kinase C. Nature
    2. (2004). Antinociceptive effects of sodium channel-blocking agents on acute pain in mice.
    3. (1982). Block of sodium current in myelinated nerve fibre with enkephalins. Neuropharmacology
    4. (2007). CM: Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities, and isolectin B4 binding in primary afferent neurons of the rat and mouse.
    5. Darstellung der reinen Mohnsäure (Opiumsäure) nebst einer chemischen Untersuchung des Opiums mit vorzüglicher Hinsicht auf einen darin neu entdeckten Stoff und die dahin gehörigen Bemerkungen.
    6. (2005). Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with adelta/ c-fibers and colocalization with trk receptors.
    7. (1995). Double in situ hybridization study on coexistence of mu-, delta- and kappaopioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia. Brain Res Mol Brain Res
    8. (2006). DP: TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction. Neuron
    9. (2002). DR: Chemical coding of neurons expressing delta- and kappa-opioid receptor and type I vanilloid receptor immunoreactivities in the porcine ileum. Cell Tissue Res
    10. (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain
    11. (1989). Facilitatory effects of opioids on the discharges of visceral nociceptors. Brain Res
    12. (1991). Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine.
    13. (1984). Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation. J Allergy Clin Immunol
    14. (1980). Iversen LL: Multiple opiate receptor sites on primary afferent fibres. Nature
    15. (1995). JD: Muopioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein beta gamma subunitmediated effect? Neuroscience
    16. (1993). McCleskey EW: Inhibition of Ca2+ currents by a mu-opioid in a defined subset of rat sensory neurons.
    17. (1982). Mitolo-Chieppa D: Inhibition of ionic currents in frog node of Ranvier treated with naloxone.
    18. (2000). Morphine and methadone have different effects on calcium channel currents in neuroblastoma cells. Brain Res
    19. (2000). MR: Inflammatory mediators in normal, sensitive and diseased skin types. Acta Derm Venereol
    20. (1973). Nature of the morphine receptor present in the squid axon. Proc Soc Exp Biol Med
    21. (2004). Neuhof H: Visualisation of tissue kallikrein, kininogen and kinin receptors in human skin following trauma and in dermal diseases. Biol Chem
    22. (1986). Onofrio BM: High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications. Anesthesiology
    23. (2008). Opioid complications and side effects. Pain Physician
    24. (2008). Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations.
    25. (2003). Pasternak GW: Analgesic synergy between topical morphine and butamben in mice. Anesth Analg
    26. (2003). Patapoutian A: ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell
    27. (2001). Peripheral opioid analgesia. Curr Opin Pharmacol
    28. (2006). Radiation dermatitis: clinical presentation, pathophysiology, and treatment
    29. (1998). Reeh PW: A technique for fast application of heated solutions of different composition to cultured neurones.
    30. (2001). Reeh PW: Interactions of inflammatory mediators stimulating release of calcitonin gene-related peptide, substance P and prostaglandin E(2) from isolated rat skin. Neuropharmacology
    31. (2003). Reisfield GM: Morphine hyperalgesia: a case report.
    32. (2000). Sheardown SA: Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature
    33. (1986). Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis.
    34. (1997). SM: Opioid receptors on peripheral sensory axons. Brain Res
    35. (1969). Synthetic interstitial fluid for isolated mammalian tissue. Life Sci
    36. (1997). The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature
    37. (1998). The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron
    38. (2008). The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neurons.
    39. (1986). Tsien R: Fura-2: a powerful new tool for measuring and imaging [Ca2+]i in single cells. Prog Clin Biol Res
    40. (2008). Undem BJ: Expression and function of the ion channel TRPA1 in vagal afferent nerves innervating mouse lungs.
    41. (2008). Undem BJ: Relative contributions of TRPA1 and TRPV1 channels in the activation of vagal bronchopulmonary C-fibres by the endogenous autacoid 4-oxononenal.
    42. (2003). Yildiz O: Topical cannabinoid enhances topical morphine antinociception. Pain
    43. (2003). Zochodne DW: Mu opioid receptors and analgesia at the site of a peripheral nerve injury. Ann Neurol

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.